BeStock  
Markets › Compare › ARQT vs TARS

ARQT vs TARS

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
ARQT · Arcutis Biotherapeutics$26.36 ▼ 2.98%
TARS · Tarsus Pharmaceuticals$73.01 ▼ 6.00%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

617487100114Nov 24, '25May 26, '26Nov 20, '26
  • ARQT -14.3%
  • TARS -11.1%

Head to head

MetricARQTTARS
Price$26.36$73.01
Change today▼ 2.98%▼ 6.00%
Market cap$3.33B$3.60B
Return, 3 months+6.4%+0.3%
Return, year to date-9.2%-10.8%
Return, 1 year-10.6%-8.3%
P/E (TTM)119.8–
P/B13.734.6
P/E percentile vs own 5y99th90th
Dividend yield––
Revenue growth (YoY, latest qtr)+45.1%+63.9%
Net profit growth (YoY)+18.8%-5,210.6%
Gross margin91.2%93.2%
Operating margin6.9%-102.3%
Net margin5.9%-102.9%
Return on equity14.9%-319.8%
Analyst target vs. price+59.3%+44.6%
Analyst buy share100%100%
RSI (14)4248
30-day volatility90.4%48.8%
Max drawdown, 1 year-37.5%-32.0%
Trend readLeaning bearishLeaning bearish
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • TARS is the largest of the group by market value.
  • TARS has returned the most over the past year.
  • TARS is growing revenue fastest.
  • ARQT keeps the most profit per dollar of sales.
  • TARS has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top